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Randomized comparison of split tip versus step tip high-flow Approximately 210,000 patients currently undergo he-
hemodialysis catheters. modialysis in the United States [1]. While the majority
Background. Our purpose was to compare the function and of these patients have permanent forms of access such
complications of two high-flow polyurethane hemodialysis
as native fistulae or synthetic arteriovenous shunts, acatheters.
large number of patients require temporary tunneledMethods. This prospective, randomized trial compared the
Ash-Split (MedComp) and Opti-Flow (Bard Access Systems) hemodialysis catheter placement during maturation of
catheters. All patients referred for tunneled hemodialysis cath- shunts and fistulae, and a subset of patients use these
eter placement were offered entry in the study, provided they catheters as their permanent form of access. In fact, the
met inclusion criteria. Catheters were placed by interventional
2001 USRDS showed an increase in tunneled catheterradiologists using ultrasound and fluoroscopic guidance. Pro-
use of 71% from 1996 to 1999, paralleling an increase incedure time and initial complications were recorded. Effective
fistula use [1]. In addition, temporary tunneled catheters(QbEff) catheter flow rates and recirculation were studied at
baseline, one month, three and six months using ultrasonic di- for hemodialysis are used in the setting of renal trans-
lution (Transonic) at various pump speeds (Qb). Episodes of plantation as well as intermittently in patients with com-
catheter malfunction and infection were recorded. Catheter plications of continuous ambulatory peritoneal dialysisremoval or six months was the study endpoint.
(CAPD). The total number of dialysis catheter place-Results. A total of 132 patients were enrolled in the trial.
ments in the United States is difficult to determine butThe groups did not differ as to age, sex distribution, height or
weight (P  0.05). Initial complications included kinking re- was estimated at 265,000 for the year 2000 (personal com-
sulting in catheter failure (Optiflow N 3), and tunnel bleeding munication; Tony Madison, MedComp, September 2001).
(Optiflow N  1; Ash N  3). Adjusted mean flow rates While percutaneous imaging guided placement of these
(QbEff) at Qb300 were 299 mL/min Ash and 305 mL/min
catheters is associated with a very low short-term compli-Optiflow (P  0.06), at Qb400 were 365 mL/min Ash and
cation rate [2–8], these catheters are prone to long-term382 mL/min Optiflow (P  0.01), and at QbMax were 414 mL/
min Ash and 433 mL/min Optiflow (P  0.03). Recirculation complications that include infection and poor flow, often
was significantly higher with the Optiflow catheter at most due to thrombosis and/or fibrin sheaths. A short-term
measurement points. Total late complications were lower in study of a new high-flow catheter design [4] showed that
the Ash group (P  0.04), and catheter survival was signifi-
the thin-walled polyurethane split-tip Ash Split hemo-cantly higher in the Ash group (P  0.02).
dialysis catheter (MedComp, Harleysville, PA, USA)Conclusions. Both catheters can deliver flow rates well be-
had superior flow rates compared with a conventional sili-yond those recommended by the Dialysis Outcomes Quality
Initiative. While the Optiflow delivered higher flow rates at some cone step-tip catheter. Other comparative studies have
measurement points, this was offset by higher recirculation. shown similar results [5, 8, 9]. A postulated but unproved
The Ash catheter showed a long-term survival advantage and additional benefit of the split tip catheter is a reductionfewer late complications.
in fibrin sheaths and hence late malfunction. The two
lumens of the catheter are fused throughout the proximal
shaft, which allows it to pass through a single tunnel, butKey words: dialysis catheters, catheterization, central venous access,
thrombosis, fibrin sheaths, polyurethane catheter. split in its distal (intravenous) portion. Like the Tesio
twin catheter (MedComp), reported to have better flowReceived for publication November 12, 2001
and lower thrombotic and infectious complicationsand in revised form January 23, 2002
Accepted for publication February 14, 2002 [10, 11], the design of these tips might reduce thrombosis
because of their constant motion relative to each other. 2002 by the International Society of Nephrology
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The previous short-term study did not evaluate this long- was 1.5 or less and the platelet count was greater than
50,000/mm3. Conscious sedation was used in all patientsterm potential benefit [4]. A primary reason for this is
that the Ash Split catheter was compared to a catheter and lidocaine without epinephrine was used for local
anesthesia. No antibiotics were administered. A sterilewith lower flow rates; thus, any differences in fibrin sheath
formation (usually detected by diminishing flow rates) environment was maintained in the IR suite during the
procedure, with full scrub by operator(s), surgical prepmight have been masked by the marked difference in
catheter design. of patient and hat and mask for every person in the
room, including the patient. A 21 G needle and coaxialIn 1999 a new hemodialysis catheter, nearly identical
to the Ash Split catheter except for its conventional step access system (Micropuncture, Cook Inc, Bloomington,
IN, USA) were used in every procedure. Since the differ-tip, was introduced. Like the Ash catheter, the OptiFlow
(Bard Access Systems, Salt Lake City, UT, USA) is a ence between the two catheters was readily apparent,
this was not a blinded study. Identical catheter lengthsthin-walled polyurethane design; it is slightly larger than
the 14F Ash at 14.5F. The larger diameter and thinner (19 cm tip to cuff, 28 cm tip to hub, 40 cm overall) were
used in each group. In the split tip group a 10 cm splitwalls compared to conventional silicone step-tip cathe-
ters are designed to provide better flow rates. This cathe- was used. Operators were able to choose between a
parasternal and lateral tunnel [3] at their discretion (Dis-ter has been shown to have superior survival compared
with an older design [5]. The similarity in design of the cussion section). After catheter insertion, the venotomy
site was closed with tissue adhesive (Dermabond; Eth-Optiflow and Ash catheters offers the opportunity to de-
termine whether the split tip design is of value in pre- icon, Somerville, NJ, USA) or 2-0 nylon suture (Ethilon;
Ethicon) at the operator’s discretion. The catheter wasventing late catheter malfunction with very few confound-
ing variables. The purpose of this study was to compare secured to the skin at the exit site with 2-0 nylon suture.
Catheters were dressed with a semipermeable dressingthe split tip catheter design to the step tip design with
specific attention to early and late catheter malfunction. (Centurion SorbaView; Tri-State Hospital Supply, How-
ell, MI, USA).Further, since fibrin sheaths and infection are thought
All catheters were placed by fellowship-trained inter-to be interrelated [10, 12–14], clinically evident infection
ventional radiologists and/or interventional radiologyalso was evaluated.
fellows with direct staff supervision. At the time of ini-
tial catheter placement, handling characteristics of each
METHODS catheter were determined by recording the insertion time
The Society of Cardiovascular and Interventional Ra- (time from local anesthesia to final suture) as well as any
diology (SCVIR) reporting standards for central venous problems or complications associated with catheter in-
access have been applied except as noted below [15]. sertion. Total room time (from time patient entered the
This was a prospective, randomized trial approved by room until the time they left the room) also was recorded.
the Institutional Review Board. All patients referred Correct catheter placement was confirmed with an erect
to the Interventional Radiology (IR) Department for anteroposterior chest radiograph performed in the IR
tunneled hemodialysis catheter placement were consid- suite using a portable unit.
ered for the study. To be eligible, patients had to be
Post-procedure care and definitionsundergoing hemodialysis using the catheter at one of
two local dialysis units, both operated by the same ne- Following catheter placement, initial maximum sus-
phrology group and both using identical catheter care tainable flow rates and recirculation were measured us-
protocols. Exclusion criteria included previous enroll- ing the ultrasonic dilution technique (Transonic HD01;
ment in the study, prisoners, patients unable or unwilling Transonic Systems, Ithaca, NY, USA) as described pre-
to sign informed consent, and patients in whom the right viously [4]. Effective flow rates (Qbeff) were determined
internal jugular vein was occluded. Further, patients who at pump speed settings (Qb) of 200, 300, 350 and 400 mL/
would not be able to participate in the six-month follow- min. In addition, maximum sustainable flow rates were
up regimen were excluded. Only right internal jugular recorded, defined as the Qbeff when the Qb was set to
vein catheter placements were studied in order to mini- the highest setting on the dialysis pump that could be
mize the number of variables. After signing informed sustained for a minimum of three minutes without setting
consent, patients were randomly assigned to receive ei- off the alarms. The dialysis machines used in our units
ther the split tip (Ash Split) or the step tip (OptiFlow) are Cobe Centry System 3. Our standard setting for ar-
catheter. Randomization was performed using random terial pressure is 300 mm Hg with alarms at25 mm Hg.
number generation. Recirculation was measured using the same device. Fur-
Catheter placement was performed as previously de- ther, the mean flow rate for the entire dialysis session
scribed [3]. Coagulation parameters were corrected if was determined using the formula: total liters processed
divided by time on dialysis [8, 16–18]. Other parametersnecessary such that the International Normalization ratio
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recorded included treatment for infection or catheter Data analysis
thrombosis. The use of low-dose thrombolytic dwell was Kaplan-Meier survival curves were estimated for both
not specifically recorded; however, during the course groups using standard definitions of primary and second-
of this study this treatment was performed very infre- ary patency. Primary patency began with catheter inser-
quently due to the removal of urokinase from the U.S. tion and ended with any intervention to restore catheter
market and subsequent delays in approving a substitute. patency (thrombolytic infusion, catheter exchange) with
Also recorded were the results of radiological studies the exception of low dose thrombolytic dwell. This defi-
prompted by poor flow rates, as well as catheter ex- nition corresponds to “initial device service interval” in
changes and the reason for eventual catheter removal. the SCVIR document [15]. Secondary patency included
After the baseline examination performed within one all interventions to maintain a functional catheter includ-
week of catheter placement, follow-up was performed ing thrombolytic infusion and exchange, and ended with
at one, three and six months with identical measurements catheter removal. This definition corresponds to “total
to baseline. The study endpoint was six months or cathe- access site service interval” in the SCVIR document. “Re-
ter removal. Reversal of bloodlines was not considered vised secondary service interval” referred to in the
an end point for catheter removal. SCVIR document was not used in this study, as the study
Catheters were flushed with 5000 units heparin/lumen was not designed to evaluate the results of interventions
after placement and after each dialysis session by dialysis to restore catheter patency.
unit personnel. Dressing changes were performed and the Descriptive statistics were calculated for all variables.
catheter entrance site was inspected three times weekly For continuous variables, these included means and stan-
(that is, at each dialysis session) for signs of infection. dard deviations. Descriptive statistics for categorical vari-
Definitions of infection conformed to SCVIR reporting ables included proportions for the binary data. Rates of
standards [15]: exit site infections were defined as evi- late complications per 100 catheter days were also calcu-
dence of infection (redness/swelling/drainage) within 2 lated. To assess equivalence, we calculated the (one-
cm of the exit site and were treated with intravenous sided) upper 95% confidence interval (95% CI) for the
antibiotics. If after 48 hours the signs of infection were
difference in proportions of complications. t tests were
still present the catheter was removed. Tunnel infections
used to compare the demographics, and room and proce-were defined as evidence of infection in the tunnel more
dure times between the two catheters. Fisher’s exact testthan 2 cm from the exit site. Bacteremia and tunnel in-
was used to test for differences in proportions of compli-fections were treated according to the protocol of Beath-
cations and gender distribution between the two cathe-ard [19], with over-the-wire exchange coupled with three
ters. Wilcoxon rank-sum test was used to test for differ-weeks of antibiotic therapy for bacteremia; and over-
ences in recirculation rates and various flow rates at eachthe-wire exchange, antibiotics and a new tunnel (preserv-
visit between the two catheters. Repeated measures anal-ing the initial venotomy site) for tunnel infections. Cathe-
ysis of variance was used to determine if the catheterster related sepsis was considered an absolute indication
differed on Qb300, Qb400, QbMax, and mean flow ratefor catheter removal.
after adjusting for visit. Adjusted means were calculatedCatheter malfunction was defined as flow rates below
for the two catheters. Kaplan-Meier estimates of the sur-300 mL/min [20]. Our protocol for catheter malfunction
vivor function were plotted to provide an overall visualcalled for initial treatment with low-dose thrombolytic
representation of the data. The log-rank test was usedagents (5000 units urokinase/lumen or 2 mg rt-PA/lumen;
to compare the survival curves for each catheter. Analy-Genentech, South San Francisco, CA, USA), but as
sis was carried out using the SAS statistical packagenoted above, this treatment was performed only rarely
(version 8.1; SAS, Cary, NC, USA).by the dialysis units during the study period. Patients
failing low-dose thrombolytic dwell were treated with
Sample size calculationurokinase infusion 30,000 units per lumen per hour for
It was anticipated that initial flow rates would differfour hours according to standard dialysis unit protocol
little between catheters based on preliminary observa-until urokinase became unavailable, then rt-PA 1 mg per
tions made in our institution before the study began.lumen per hour for 2.5 hours thereafter [21–23]. Patients
Assuming the hypothesis that split tip catheters are lessfailing both thrombolytic treatments or with a contra-
prone to fibrin sheath formation is true, we would expectindication to thrombolysis were treated with over-the-
catheter malfunction (and possibly infection) to be less inwire catheter exchange [24–26] and fibrin sheath disrup-
the Ash Split group. In a prior study, thrombosis-relatedtion [25] as needed. Decision between the latter was
catheter malfunction with a step tip design occurred inbased on angiographic visualization of a fibrin sheath
14% of catheters [3]. Our experience at the outset ofduring exchange; if an extensive sheath was seen, it was
this study [4 and unpublished data] suggested that suchdisrupted through the same access site. Transfemoral
fibrin sheath stripping was not performed in any patient. problems occurred between 4 and 6% of the time with
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Table 2. Late complicationsTable 1. Descriptive statistics and initial procedure
Ash Optiflow Ash Optiflow
(N  64)a,b (N  68) P
Total late complications 16 (0.22) 29 (0.43)
Infection (total) 9 (0.12) 15 (0.22)Age 53.314.3 56.212.9 0.21
Male 37 (57.8%) 46 (67.6%) 0.28 Requiring removal 6 (0.08) 11 (0.16)
Not requiring removal 3 (0.04) 4 (0.06)Height inches 66.94.4 68.24.0 0.10
Weight pounds 174.857.3 187.846.0 0.15 Poor flow/fibrin sheath 7 (0.10) 6 (0.09)
MechanicalBMI 27.27.8 28.77.6 0.27
Room time (mean  SD) 57.318.0 58.213.4 0.74 Hub crack 0 (0.00) 3 (0.04)
Tip separation 0 (0.00) 1 (0.01)Lateral tunnel 30 (47%) 53 (78%) 0.0001
Procedure time (mean  SD) 22.410.9 21.110.2 0.49 Kinking 0 (0.00) 1 (0.01)
Cuff extrusion 0 (0.00) 1 (0.01)Complications % 10 (15.6%) 12 (17.6%) 0.82
Bleeding % 3 (4.7%) 1 (1.5%) 0.35 Jugular thrombosis 0 (0.00) 1 (0.01)
Innominate vein occlusion 0 (0.00) 1 (0.01)Kinking % 7 (10.9%) 11 (16.2%) 0.45
Numbers in parentheses represent events per 100 catheter days. P  0.04,a For Room time only 62 observations used since other procedures performed
in conjunction with catheter placement Fisher’s exact test.
b For Lateral tunnel, 1 subject had both lateral and parasternal attempted
found in procedure or room time between catheter types.
the Ash Split catheter, but this was based on a small short- Although parasternal versus lateral tunnel location was
term series (total 50 catheters over six weeks compared at the operator’s discretion, lateral tunnels were used
with 1000 traditional catheters over many months). more frequently in the Optiflow group (78 vs. 47%, P 
Detecting a difference in fibrin sheath formation be- 0.0002; Discussion section).
tween catheters (assuming the split tip numbers were Twenty-one patients were excluded from flow data
correct) would require an inordinately large sample size. analysis, 14 because they were transferred to another di-
We decided to take a null hypothesis approach. alysis unit outside our system after the catheter was
The power of the study was estimated using an equiva- placed, three because of catheter kinking (see below),
lence test of proportions. With a sample size in each group two because of catheter removal after a single dialysis
of 59, a two-group large-sample normal approximation session, and one each due to a cracked hub and patient
test of proportions with a one-sided 0.05 significance refusal to participate further. Thus, 111 patients had flow
level would have 80% power to reject the null hypothesis information, one of whom did not have a baseline data
that the proportion of late complications with Ash (pAsh) set. One-month flow data were obtained in 82 patients,
and Optiflow (pOptiflow) catheters were not equivalent in three-month data in 54 patients, and six-month data in
favor of the alternative hypothesis that the proportions 29 patients. Complete data on catheter survival and long-
in the two groups are equivalent, assuming that the ex- term complication were available for 128 catheters.
pected proportion of late complications in the Ash group Mean catheter dwell time was 107 days (114 Ash, 100
is 0.05 and the expected proportion of late complications Optiflow), total catheter days in the study was 13,953
in the Optiflow group is 0.13. Thus, we wished to enroll (7267 Ash, 6686 Optiflow).
a minimum of 59 patients in each group. The six-month
Complicationsend point was used based on our average catheter dwell
time of three months, as we knew that by six months As seen in Table 2, the complication proportion was
most catheters would have been removed. 25% for Ash and 42.6% for Optiflow. The end point of
the 95% upper confidence interval for the difference
(Optiflow-Ash) in proportions was 0.275, indicating aRESULTS
lack of equivalence. This difference was statistically sig-
Demographics nificant (P 0.04, Fisher exact test). Because of the lack
One hundred thirty-two patients were enrolled in the of power, no comparison of individual complications was
trial (64 split tip, 68 step tip), and 76 (58%) had had no made. Initial complications (Table 1) included kinking
prior catheters. The groups did not differ in age (split resulting in immediate failure (Optiflow N  3) and
tip mean 53 years, step tip mean 56 years, P  0.21), tunnel bleeding (Optiflow N  1; Ash N  3). Kinking
height (split tip mean 66.9 inches, step tip mean 68.2 was described as a problem during catheter insertion
inches, P 0.10), or weight (split tip mean 174.8 pounds, in 11 Optiflow procedures and 7 Ash procedures. Late
step tip 187.8 pounds, P  0.15). Sex distribution was complications (Table 2) did not differ between groups
similar in both groups (split tip 27 F, 37 M; step tip 22 F, and included kinking requiring removal (Optiflow N 
46 M, P  0.28). 28 patients in each group had had prior 1), fibrin sheath/poor flow (Optiflow N 6, Ash N  7),
catheters (P  0.76). These data are summarized in Ta- infection requiring removal (Optiflow N  11, Ash N 
6), infection not requiring removal (Optiflow N 4, Ashble 1, along with procedural data. No differences were
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Table 5. Flow dataTable 3. Recirculation
Ash Optiflow Ash Optiflow
Month N Mean SD N Mean SD P Month N Mean SD N Mean SD P
Qb300 0 55 304 28 55 306 26 0.2158RPER300 0 55 1.6 5.0 55 5.4 8.1 0.0003
RPER400 0 53 1.6 4.0 52 7.9 10.4 0.0001 Qb400 0 53 380 41 52 390 55 0.0912
QbMax 0 53 436 50 53 434 66 0.5890RPERmax 0 53 2.7 6.3 54 8.8 11.5 0.0012
MFR 0 40 356 38 30 346 43 0.1958
RPER300 1 42 3.1 5.9 40 4.7 7.3 0.2636
RPER400 1 41 4.9 9.2 40 6.6 9.0 0.2277 Qb300 1 42 293 34 40 308 26 0.0340
Qb400 1 41 360 59 40 391 40 0.0008RPERmax 1 40 4.7 8.5 38 8.1 10.8 0.1324
QbMax 1 40 407 75 38 455 34 0.0007
RPER300 3 28 1.5 3.6 26 4.2 6.4 0.0509 MFR 1 26 351 42 21 361 32 0.6921
RPER400 3 27 1.5 4.4 26 7.2 7.8 0.0003
RPERmax 3 27 1.7 3.8 26 9.5 9.5 0.0001 Qb300 3 28 297 25 26 311 23 0.0291
Qb400 3 27 364 41 26 381 22 0.1371
RPER300 6 14 1.3 4.8 15 3.5 6.8 0.2074 QbMax 3 27 393 69 26 434 32 0.0179
RPER400 6 14 2.4 6.2 15 5.7 7.9 0.3410 MFR 3 18 356 33 14 378 40 0.1063
RPERmax 6 12 0.5 1.2 14 3.7 7.5 0.6269
Qb300 6 14 307 21 15 292 28 0.2563Values are expressed as percent at Qb of 300, 400 and maximum (see text).
Qb400 6 14 363 44 15 366 52 0.6004Month denotes baseline (0), 1, 3 and 6 month readings. SD is standard deviation,
QbMax 6 12 424 53 15 416 74 0.9611N is the number of observations.
MFR 6 6 366 22 3 390 10 0.0933
Values are expressed as mL/min at Qb of 300, 400 and maximum (see text).
Month denotes baseline (0), 1, 3 and 6 month readings. Abbreviations are: Qb,
pump speed; SD, standard deviation; N, number of observations; MFR, mean
Table 4. Adjusted means from repeated measures analysis flow rate.
Ash Optiflow P
Qb300 299 305 0.0631
Qb400 365 382 0.0079 Flow rates/recirculation
QbMax 413 433 0.0248
Ultrasonic dilution data are shown in Tables 3 to 5.MFR 362 364 0.8471
Adjusted mean flow rates (QbEff) at Qb300 were 299Values expressed as mL/min at Qb of 300, 400 and maximum (see text). MFR
is mean flow rate. mL/min Ash and 305 mL/min Optiflow (P  0.06), at
Qb400 were 365 mL/min Ash and 382 mL/min Optiflow
(P  0.01), and at QbMax were 413 mL/min Ash and
433 mL/min Optiflow (P  0.02). As can be seen from
N  3), mechanical catheter failure (Optiflow N  4; Table 5, the Optiflow catheter delivered significantly
three cracked hubs and one tip separation), cuff extru- higher effective flow rates at all pump speeds tested at
sion (Optiflow N 1), symptomatic internal jugular vein the one month interval, and significantly higher effective
thrombosis (Optiflow, N  1), and innominate vein oc- flow rates at Qb300 and Qbmax at the three month
clusion (Optiflow, N  1). All infections occurred at a interval, but catheter flows did not differ at baseline or
rate of 0.12 per 100 catheter days in the Ash group at six months. As shown in Table 3, recirculation was
and 0.22 per 100 catheter days in the Optiflow group. significantly higher with the Optiflow catheter at all flow
Infections requiring removal occurred at a rate of 0.08 rates tested at baseline and three months, but not at one
per 100 catheter days in the Ash group and 0.16 per and six months. ‘Mean flow rate’ did not differ between
100 catheter days in the Optiflow group. Infections not groups at any interval.
requiring removal occurred at a rate of 0.04 per 100
Catheter survivalcatheter days in the Ash group and 0.06 per 100 catheter
One hundred thirty-one patients were evaluated fordays in the Optiflow group. Flow problems (poor flow,
catheter survival; one subject was lost to follow up beforefibrin sheath) requiring removal occurred at a rate of
dialysis. Survival curves are shown in Figure 1. The log0.10 per 100 catheter days in the Ash group and 0.09 per
rank test revealed a significant difference (P  0.022)100 catheter days in the Optiflow group.
between the survival curves for each catheter type, withThe patient with tip separation was referred to Inter-
the Ash demonstrating a survival benefit as comparedventional Radiology because of poor flow, and upon
to the Optiflow. Reasons for catheter removal are shownfluoroscopic evaluation it was discovered that the cathe-
in Table 6. Sixteen of the catheters reaching the six-ter tip had broken off and migrated to the left pulmonary
month end point were Optiflow and 22 were Ash.artery. An extensive attempt at foreign body retrieval
was unsuccessful (Discussion section). Because of this,
DISCUSSIONthe remaining two patients with Optiflow catheters in
the study at that time had elective exchange for Ash Despite the known drawbacks of tunneled hemodialy-
sis catheters, including infection and venous thrombosis,catheters at 107 and 116 days.
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Fig. 1. Overall catheter survival (log-rank
value  0.0215).
Table 6. Reasons for removing catheter not change. This recommendation persists at least in part
because there is no evidence to date to suggest thatReason Number
the newer catheters offer benefit in terms of reducedFinished study 40
Mature access 25 infection, an important and potentially lethal complica-
Recovered 6 tion of tunneled catheters.
CAPD 5
Catheter survival and flow have been the subject ofCracked hub 3
Cuff extrusion 1 several studies evaluating the newer catheter designs. In
Died 9 a non-randomized study, Rocklin et al showed that the
Fibrin sheath 5
Optiflow catheter had a lower (but not statistically sig-Infection 17
Kink 4 nificant) probability of catheter failure than the Bard
Poor flow 7 Hickman silicone dialysis catheter [5], but both catheters
Product recall 2
had similar infection rates. Richard et al, in a semi-ran-Jugular thrombosis 1
Stopped dialysis 1 domized study, compared the AshSplit, Optiflow, and
Tip separation 1 Tesio catheters; they found no statistically significantTransplant 1
differences in catheter survival and infection rates, butLost to follow-up 4
higher initial complications with the Tesio catheter [8].Total 132
Neither study evaluated flow rates using an ultrasonicCAPD is continuous ambulatory peritoneal dialysis.
dilution technique; thus, the actual flow rates for the cath-
eters were not determined. Trerotola et al used the ultra-
sonic technique to show superior flow rates for the Ash
these devices are essential to the seamless delivery of catheter compared to the Bard Hickman catheter, but
hemodialysis. Optimally, catheters should serve as a did not evaluate long-term catheter survival [4]. Mankus,
bridge to more permanent access, ideally an arteriove- Ash and Sutton reported a nonrandomized series com-
nous fistula. The 1997 DOQI guidelines emphasized that paring the Mahurkar, Tesio and Ash catheters in which
less than 10% of patients should have catheters as their the ultrasonic dilution technique was used to evaluate
permanent access [20]. Since the 1997 guidelines were flow rates [9]. The Tesio and Ash catheters had compara-
published, some important advances in tunneled cathe- ble flow rates while the Mahurkar rates were lower, but
ters have occurred, prompting the 2001 K/DOQI guide- this was not statistically significant in this small series.
lines to advocate “high-flow” catheters [27]. This recom- Catheter survival was not evaluated. Prabhu et al applied
mendation acknowledges recent work that has shown a the ultrasonic dilution technique to the Tesio catheter,
clear-cut benefit of the newer high-flow catheters in reporting flow rates of 352 mL/min [6] and Leblanc et
terms of flow rates [4, 8, 9]; however the recommenda- al used the same technique with Tesio catheters and
reported QbEff on 303, 336 and 372 mL/min at pumptions regarding catheter use for permanent access did
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speeds of 300, 350 and 400 mL/min, respectively. They showed no survival benefit, conceivably due to subopti-
mal tip position [5]. The Ash catheter, while less sus-also reported recirculation of 8.5, 7.8 and 10.2% for Qb
of 300, 350 and 400 mL/min, respectively [28]. ceptible to kinking, more often had tunnel bleeding that
prompted additional maneuvers such as prolonged com-The results from the present study shed further light
on the available high-flow catheters, showing both can pression and/or DDAVP injection. This limitation ap-
pears to be due to the groove along each side of theyield flow rates well in excess of the DOQI recommenda-
tions, and showing that the Ash offers a long-term cathe- catheter, and appears to have been improved in a new
version of the catheter (Ash 2) by reducing the depthter survival benefit and lower overall complication rate
which are likely multifactorial. Although we were unable of this groove. Both catheters took the same amount of
time to insert, a finding different from Trerotola et alto test individual (such as, thrombotic or infectious) com-
plications for statistical significance due to low power, who found the Ash catheter took slightly longer to in-
sert than the step tip Bard Hickman catheter [4]. Thisthe latter were nearly twice as common with the Optiflow
than with the Ash. This combined with the mechanical could be due to more experience with the split tip cathe-
ter, or more time spent reducing kinking with the step-failures (hub cracks, tip separation, kinking) seen in the
Optiflow group may cumulatively account for the Ash tip catheter.
The differences in flow rates and recirculation ob-survival benefit. Whether the split tips themselves play
a role in the observed survival benefit cannot be stated served at one and three months are probably not clini-
cally significant within the range of flow rates normallywith certainty. It is interesting to note that while not
statistically different in their series, Richard et al also used for dialysis, and it is probable that any advantage
gained by the Optiflow in terms of effective flow rate isreported longer median catheter survivals for the Ash
(302 days) compared with the Optiflow (176 days) [8]. offset by the higher recirculation. There are differences
in the cost of the catheters, as well as certain uniqueBased on earlier work with twin catheters [10, 11],
there was some hope that the newer designs, particularly failure modes, which deserve discussion. The Ash cathe-
ter costs $395 while the Optiflow costs $280; thus, if thethe split tip design, might offer a reduction in infectious
and thrombotic complications. While neither our study catheters had performed comparably one could argue
cost-effectiveness in favor of the latter. However, thenor the study of Richard et al showed statistically signifi-
cant reductions in thrombosis or infection, both studies Optiflow has undergone two product recalls within the
past year, first for a hub cracking problem [5], and moreshowed a trend toward reduced infection: Richard et al
reported 0.35 and 0.12 episodes/100 catheter days for recently for a problem with tip separation, in which the
catheter tip breaks off and embolizes to the lung. Boththe Optiflow and Ash catheters, respectively [8], and
we report 0.22 and 0.12 episodes per 100 catheter days, of these complications occurred during the course of this
study. In fact, we had three tip separations with thisrespectively. We do not believe that the observed trend
toward lower infection with the Ash catheter in our series catheter design (two outside this study) out of a total
239 Optiflow insertions at our institution, for a rate ofwas due to differences in tunnel position since the distri-
bution of tunnel location in patients with infection was one per 80 insertions or 1.3%. In all three, retrieval of
the catheter tip was unsuccessful; one patient developedsimilar to that in the study as a whole. If larger studies
designed to specifically look at infection were to confirm a pulmonary infarct due to the catheter tip and the pa-
tient in this study with tip separation has had recurrentour observations and those of Richard et al, this could
lend credence to the “self-cleaning” tip concept, the the- episodes of bacteremia thought to be due to the foreign
body. These problems, in conjunction with the provenory being that if there is less fibrin sheath on the catheter,
there is less opportunity for bacterial colonization. survival benefit, suggest the added cost of the Ash is
justified. It should be noted that the tip separations were,From the standpoint of initial insertion characteristics,
there are subtle, if not statistically significant, differences. according to the manufacturer, associated only with spe-
cific lots of Optiflow catheters. We were unable to deter-We found early in the study that a parasternal tunnel
could not be reliably created using the Optiflow device mine whether the catheters affected in our institution
were from those lots.because this led to kinking; even using a lateral tunnel
kinking occasionally caused catheter failure. While this We believe the rigorous approach of using ultrasonic
dilution used here and by some other investigators [6,could be addressed with a precurved catheter, it is our
feeling that a precurved configuration will not allow pre- 9, 28] to determine effective flow rates rather than pump
speed and recirculation allows a more educated compari-cise tip positioning, and tip positioning is critical with
step-tip catheter designs [2]. It is possible that with multi- son between study groups, and strongly recommend that
future catheter studies adopt this approach as well. Thisple precurved lengths, this limitation could be addressed.
It should be noted that precurved Optiflow catheters is highlighted by our finding that mean flow rate, a mea-
sure often used in studies of dialysis catheters [8, 16–18],were used in the study of Rocklin et al, and kinking oc-
curred in only one catheter; on the other hand the study showed no difference between groups, while the more
Trerotola et al: Split tip vs. step tip high-flow catheters 289
catheters: Use of a silver-coated catheter for prevention of infec-accurate ultrasonic technique showed clear-cut differ-
tion—a randomized study. Radiology 207:491–496, 1998
ences. As direct flow measurement devices become more 8. Richard HM, Hastings GS, Boyd-Kranis RL, et al: A random-
ized, prospective evaluation of the Tesio, Ash Split, and Opti-Flowreadily available in the dialysis unit, it should become
hemodialysis catheters. JVIR 12:431–435, 2001relatively straightforward to use these techniques for
9. Mankus RA, Ash SR, Sutton JM: Comparison of blood flow
catheter studies. rates and hydraulic resistance between the Mahurkar catheter, the
Tesio Twin catheter, and the Ash Split cath. ASAIO J 44:M532–There are several limitations to this study. Although
M534, 1998randomized, the study could not be blinded and thus
10. Canaud B, Beraud JJ, Joyeux H, Mion C: Internal jugular vein
bias could have been introduced. Relatively few patients cannulation using 2 silastic catheters: A new simple and safe long-
term vascular access for extracorporeal treatment. Nephron 43:had catheters remaining at six months; although this is
133–138, 1986the desired result clinically, it limits the power of obser-
11. Tesio F, De Baz H, Panarello G, et al: Double catheterization
vations made late in the study. The catheters were not of the internal jugular vein for hemodialysis: Indications, tech-
niques, and clinical results. Artif Organs 18:301–304, 1994all tunneled in exactly the same fashion; hence, it is con-
12. Press OW, Ramsey PG, Larson EB, et al: Hickman catheter infec-ceivable that observed differences were somehow due
tions in patients with malignancies. Medicine (Baltimore) 63:189–
to tunneling, although this seems highly unlikely. Despite 200, 1984
13. Clarke DE, Raffin TA: Infectious complications of indwellingthese limitations, we believe the observations made are
long-term central venous catheters. Chest 97:966–972, 1990valid and worthy of further study.
14. Hernandez D, Diaz F, Suria S, et al: Subclavian catheter-related
In summary, our study showed effective flow rates for infection is a major risk factor for the late development of subcla-
vian vein stenosis. Nephrol Dial Transplant 8:227–230, 1993both catheters that exceeded the recommendations of
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